Miglitol丨CAS 72432-03-2

Miglitol丨CAS 72432-03-2
Product Introduction:
Catalog No.: SS130905
CAS No.: 72432-03-2
Purity: 98%min
Product Name: Miglitol
Molecular Formula: C8H17NO5
Molecular Weight: 207.22
Synonym(s): 1-(2-Hydroxyethyl)-2-(hydroxymethyl)piperidine-3,4,5-triol
Send Inquiry
Technical Parameters
Description

Hangzhou Leap Chem Co., Ltd. is one of the most professional manufacturers and suppliers of miglitol丨cas 72432-03-2 in China. Welcome to wholesale bulk high quality chemical products at competitive price from our factory. If you have any enquiry about custom service, please feel free to email us.

 

Specifications

 

Appearance White powder
Purity 98% min
1H NMR Spectrum Conforms to structure
Optical rotation -12.57° (C=0.56 H2O)
Structure Conforms to structure

 

 

 

Applications

 

Miglitol is an oral antihyperglycemic agent used in the management of type 2 diabetes mellitus. It functions as an α-glucosidase inhibitor, delaying the digestion and absorption of carbohydrates in the small intestine, thereby reducing postprandial blood glucose levels. Miglitol is primarily prescribed as a therapeutic agent for patients with impaired glucose tolerance or diabetes, often in combination with diet control or other antidiabetic medications. In pharmaceutical research, it is also employed as a reference compound for studying carbohydrate metabolism, enzyme inhibition, and the development of new α-glucosidase inhibitors with improved efficacy and safety profiles.

 

Benefits

 

The key benefits of Miglitol lie in its ability to effectively control postprandial hyperglycemia without stimulating insulin secretion, minimizing the risk of hypoglycemia compared to other antidiabetic agents. Its oral administration makes it convenient for patients, and it demonstrates predictable pharmacokinetics and good tolerability. Additionally, Miglitol helps reduce glycemic spikes that contribute to long-term diabetic complications such as cardiovascular disease, neuropathy, and retinopathy. By targeting carbohydrate absorption, it complements other antidiabetic therapies and supports comprehensive blood glucose management.

 

Conclusion

 

Miglitol is a valuable therapeutic agent in the management of type 2 diabetes, offering effective postprandial blood glucose control with low risk of hypoglycemia. Its role as an α-glucosidase inhibitor provides a unique mechanism of action, making it useful both in clinical treatment and pharmaceutical research. By improving glycemic regulation and supporting combination therapy strategies, Miglitol contributes significantly to diabetes care and patient quality of life.

 

Send Inquiry
Beyond Your Expectation
From Science to Life with LEAPChem
contact us